Viral Vector Development

All times below listed in ET

Co-chairs: Carol Miao, PhD, and Anna Maurer, PhD

8:00 – 8:20 a.m.

Overview of Viral Vector Platforms
Negin Martin, PhD, NIEHS

8:20 – 8:40 a.m.

Lentiviral Vector Design and Applications
Axel Schambach, PhD, Hannover Medical School

8:40 – 9:00 a.m.

Adenoviral Vector Design and Applications
Maria G. Castro, PhD, University of Michigan Medical School

9:00 – 9:20 a.m.

From the Lab to the Clinic: Designing Preclinical Programs to Assess Efficacy and Safety for Novel Viral Vectors
Eva Andres-Mateos, PhD, Atsena Therapeutics

9:20 – 9:40 a.m.
Panel Discussion

Break: 9:40 – 10:00 a.m.

10:00 – 10:20 a.m.

AAV Vector Development
Mark Kay, PhD, Stanford University

10:20 – 10:40 a.m.

AAV Capsid Engineering and Library Approaches
Ben Deverman, PhD, Broad Institute

10:40 – 11:00 a.m.

AAV Vector Production from Small to Large Scales
Nathalie Clement, PhD. Unicorn Consultations, LLC

11:00 – 11:20 a.m.

AAV Vectors:Transgene Design
Charles Venditti, MD, PhD, National Human Genome Research Institute

11:20 – 11:40 a.m.

AAV Vectors: Tropism
Weidong Xiao, PhD, Indiana University

11:40 a.m. – 12:00 p.m.
Panel Discussion